the various guanine nucleotide regulatory proteins that have been fully characterized to date.
It has been a matter of some contention as to whether insulin can exert an inhibitory effect upon adenylate cyclase activity. However, based upon our observations on the plasma-membrane cyclic AMP phosphodiesterase, it is apparent that such effects should only be observed at relatively high, but nevertheless physiological, GTP concentrations. Under such conditions we (Heyworth & Houslay, 19836) have indeed observed an inhibition of adenylate cyclase activity using low, physiological concentrations of insulin. As with insulin's action on the plasmamembrane cyclic AMP phosphodiesterase, no inhibition can be observed in broken membranes obtained from glucagon-treated ('uncoupled') hepatocytes where the putative Nin has presumably been modified. Similarly, no effect of insulin on adenylate cyclase activity can be seen in membranes from hepatocytes treated with cholera toxin where, presumably, both N,, and Nin are fully activated. The major ADP-ribosylated band in hepatocyte plasma membranes is N, and this undoubtedly exerts a dominating stirnulatory influence on adenylate cyclase in membranes from cholera toxin-treated cells and in assays containing high glucagon concentrations (Heyworth & Houslay, 19836 ).
These observations on the effect of insulin on adenylate cyclase activity lend support then to our contention that a distinct guanine nucleotide regulatory protein is involved in mediating certain of insulin's actions.
More recently we have been able to show that three distinct treatments block both the ability of glucagon to 'uncouple' adenylate cyclase activity and prevent insulin's activation of the plasma membrane cyclic AMP phosphodiesterase. These are either the pretreatment or preexposure of hepatocytes to adenosine, Ca2 + 4onophore and islet activating protein (IAP) from pertussis toxin. We believe that this emphasizes the inter-relationships between glucagon's 'uncoupling' of adenylate cyclase and its ability to block insulin's activation of the plasma-membrane phosphodiesterase (Heyworth et al., 1983b ). Importantly, it shows that glucagon can modify certain of insulin's actions at the level of the plasma membrane independently of its ability to affect intracellular cyclic AMP concentrations.
Clearly the putative Nin cannot mediate all of the effects of insulin that are exerted upon the cell. This is demonstrated by the 'dense-vesicle' enzyme whose activity is synergistically increased by treatment of hepatocytes with both glucagon and insulin. We have provided evidence that this enzyme is activated by insulin through a route which is independent from that used to activate the plasma membrane phosphodiesterase. In this case activation appears to ensue as a result of the internalization and subsequent processing of the insulin receptor or insulin itself .
The concept that insulin might exert widespread effects on cellular functioning by controlling the activity of specific membrane-bound protein kinases has been suggested by a number of investigators Houslay, 1981) . The attraction of such a hypothesis is that it would provide the necessary degree of amplification and the diversity required to account for insulin's cellular effects. We envisage here that the putative guanine nucleotide regulatory protein, Nin, may itself mediate insulin's actions on membrane-bound protein kinases and perhaps even modulate the functioning of the kinase activity which is associated with the receptor itself. Insulin has profound effects on the metabolism of fat cells. Most striking is the large increase in the rate of conversion of glucose into fatty acids which is observed within a minute or so of exposure of fat cells to insulin. This increase is brought about by the parallel activation of a number of steps in the pathway including glucose transport across the plasma membrane, pyruvate dehydrogenase (a mitochondrial enzyme) and acetyl-CoA carboxylase (a cytoplasmic enzyme). In addition, in cells in which the concentration of cyclic AMP is increased by adrenaline or other hormones, insulin may cause a marked decrease in lipolysis by lowering the activity of triglyceride lipase. Under these conditions 607th MEETING, LONDON insulin may also inhibit glycogen breakdown via effects on phosphorylase and glycogen synthase (though this is a minor pathway in these cells) (for reviews see Denton et al., 1981; .
Since many of the enzymes involved are known to be regulated by reversible phosphorylation, considerable attention has been given to exploring the effects of insulin on specific protein phosphorylation in fat cells in our and other laboratories ; Avruch et al., 1982~). It had been argued that a common element in the action of insulin would be the dephosphorylation of enzymes (Cohen, 1984; Ingebritsen & Gibson, 1980) . Indeed it is possible to demonstrate directly the dephosphorylation of pyruvate dehydrogenase and under appropriate conditions that of triglyceride lipase (Hughes et al., 1980; Nilsson et al., 1980) . However, the most easily detected changes are, in fact, increases in phosphorylation ( Table 1 ). The most prominent is the increased phosphorylation of ATP citrate-lyase (Pierce et al., 1981 , but no appreciable changes in catalytic activity have been observed associated with this increase in phosphorylation. Other examples include acetylCoA carboxylase which will be described in more detail in the following section, the ribosomal protein s 6 , and the psubunit of the insulin receptor. It is possible that the increased phosphorylation of the ribosomal protein s 6 may be the basis of the increases in protein synthesis observed in fat and other cells (Perisic & Traugh, 1983 ). In addition, there are a number of proteins of unknown function including a protein of M, 61 000 associated with the plasma membrane and a cytoplasmic protein of M , 22000 (Belsham et al., 1980 (Belsham et al., , 1982 Blackshear et al., 1982) . This latter protein shows the largest percentage increases inphosphorylation (of the order of 5-10-fold). The protein is thermostable and not precipitated by 1-2% trichloroacetic acid, which are properties shown by a number of other similar sized proteins which have important regulatory functions, such as inhibitor-1, myosin light chain, G-protein and calmodulin. The role of this protein remains an intriguing problem. We have speculated previously that increased phosphorylation of this protein may play a role in initiating the dephosphorylation of other proteins in cells exposed to insulin, including glycogen synthase and triglyceride lipase, perhaps through activation of protein phosphatase activity . The increases in phosphorylation summarized in Table 1 appear to be very largely confined to serines (acetyl-CoA carboxylase, ATP citrate-lyase, S , and the 22K-protein). Only the increased phosphorylation of the P-subunit of the insulin receptor has been reported to involve an enhanced amount of tyrosine phosphorylation. But even in this case, most (perhaps more than 90%) of the increased phosphorylation observed within intact tissue may occur on serine and threonine residues . It is evident that a number of different protein kinases may be involved in the mechanism of action of insulin. The rest of this paper is concerned mainly with summarizing our recent studies on protein kinase activity involved in the increased phosphorylation of acetyl-CoA carboxylase and ATP citrate-lyase.
Phosphorylation of acetyl-CoA carboxylase in fat cells and its role in the regulation of activity
The phosphorylation of acetyl-CoA carboxylase within the fat cell can be readily demonstrated by following the rapid incorporation of 32Pl from medium phosphate into the enzyme isolated from tissue extracts by a combination of immunoprecipitation and SDS/polyacrylamide gel electrophoresis (Brownsey et al., 1977) . Both insulin and adrenaline were found to cause modest increases in the steady state level of 32P, incorporation into the enzyme. This was somewhat surprising, initially, as under these conditions insulin causes a doubling in the initial activity of acetyl-CoA carboxylase, whereas adrenaline resulted in a more than 30% decline in activity . Because studies with purified acetyl-CoA carboxylase from mammary gland suggested that phosphorylation could occur at multiple sites in the enzyme (Hardie & Cohen, 1978 ) the extent of multi-site phosphorylation was explored in fat cells .
Fat cells were incubated with 32Pl in the presence or absence of hormones, 32P-acetyl-CoA carboxylase was isolated by immunoprecipitation, and peptides released by trypsin digestion separated by a two-dimensional system. Three groups of 32P-labelled peptides were separated and designated the C, A and I groups. Adrenaline but not insulin increased incorporation into the A group about twofold whereas insulin increased incorporation into the I group some fivefold. The I group appeared to contain only one peptide. Incorporation into this site was also increased by adrenaline but to a smaller extent. Neither hormone affected the phosphorylation of the C group of peptides. These results indicated that treatment of fat cells with insulin and adrenaline led essentially to the phosphorylation of different sites on acetyl-CoA carboxylase and that these different patterns of phosphorylation might be associated with the opposite changes in the activity. The sites phosphorylated in cells exposed to adrenaline appear to be the same as those phosphorylated by cyclic AMP-dependent protein kinase (Brownsey & Hardie, 1980 ; R. W. Brownsey, unpublished work).
Protein kinases involved in the increased phosphorylation of acetyl-CoA carboxylase and A TP citrate-lyase in fat cells exposed to insulin
The finding that insulin increases the phosphorylation of a specific site on acetyl-CoA carboxylase raised the question of the protein kinase involved. Purified fat cell plasma membranes were found to contain substantial protein kinase activity which was capable of phosphorylating acetyl-CoA carboxylase with concomitant activation of the enzyme . This kinase activity was found to employ MgATP, to be insensitive to cyclic Table 2 ). These fractions were prepared as rapidly as possible using a Beckman Airfuge. Substrates for the kinase include both endogenous and added purified acetyl-CoA carboxylase and ATP citrate-lyase. In addition, increased phosphorylation of two unknown proteins of M , 78000 and M, 43 000 is also evident in the high-speed supernatant from insulin-treated adipose tissue. The properties of this protein kinase appear to be similar to the cyclic AMP-independent activity found associated with fat cell plasma membranes. In particular peptide maps of acetyl-CoA carboxylase suggest that the Isite is the major site phosphorylated. The kinase activity is not apparently altered by CaZ+, cyclic nucleotides or the Walsh inhibitor. There seems little doubt that insulin leads to a substantial increase in cytoplasmic protein kinase activity able to phosphorylate at least two of the proteins exhibiting enhanced phosphorylation in cells exposed to insulin. We have not been able to detect any increase in activity associated with crude particulate or purified plasma membranes prepared from adipose tissue previously incubated with insulin. In fact, there appears to be a small decrease. A problem with these studies is the presence of ATPase activity in subcellular fractions. Although the amount is not altered by insulin-treatment it does limit the extent of protein phosphorylation that can be achieved. For example, the extent of phosphorylation of acetyl-CoA carboxylase in supernatant fractions is insufficient to cause a detectable change in activity. Further studies are also clearly necessary to characterize the protein kinase activities, and in particular the inter-relationship between the plasma membrane and supernatant forms.
Comments on the role of protein kinases in insulin action
The increase in protein kinase activity in the high-speed supernatant fraction of insulin-treated tissue is very persistent and is essentially unaffected by dialysis or gel filtration (Brownsey et al., 1984) . Although it is possible for a tightly bound regulator to remain attached during such a procedure, it is unlikely. The more likely explanations are either that the kinase has undergone some covalent modification (such as a change in phosphorylation) or there has been translocation from other sites in the cell (such as the plasma membrane). Our findings are quite similar to those of a number of laboratories who have been studying the increased phosphorylation of the ribosomal protein S6 in 3T3-LI and other cells (Smith et al., 1980; Perisic & Traugh, 1983) . As with acetyl-CoA carboxylase it appears that the sites phosphorylated in cells exposed to insulin are different from those phosphorylated by cyclic AMP-dependent protein kinase. Moreover, the activity of the cyclic nucleotide-independent protein kinase apparently involved in the action of insulin is elevated in subcellular fractions from insulin-treated cells. Our observations to date are compatible with a working hypothesis we first put forward in 1981 . The essence of this hypothesis is that the binding of insulin to its plasma membrane receptors may lead to activation of protein kinase activity on the inner face of the plasma membrane. We suggested that the means of activation might be the dissociation of the kinase from specific sites on the inner face of the membrane. Subsequently, it has become increasingly evident that a characteristic of insulin action on cells may be the rapid translocation of components between plasmamembrane locations. Examples include both the recruitment of glucose transporters from intracellular sites (Karnieli et al., 1981; Kono et al., 1982) and the rapid internalization of insulin-receptor complexes (Olefsky & Kao, 1982; Desbuquois et al., 1982; Khan et al., 1982) .
Another attraction of our hypothesis is that it does offer a means of amplification of the insulin signal. It has been suggested that the effects of insulin may be brought about by a mediator, probably a peptide acting directly on a number of enzymes. These enzymes include cyclic AMP-dependent protein kinase, glycogen synthase phosphatase, pyruvate dehydrogenase phosphatase and phosphodiesterase (Lamer er al., 1982; Jarett et al., 1982) . However, there are at least a million molecules of each of these targets in a fat cell. In contrast, less than 500 insulin receptors need to be occupied to bring about maximal effects of the hormone. It is very difficult to visualize how the binding of insulin to a receptor could result in the release of such a large number of mediator molecules (especially if the mediator was a peptide generated by proteolysis from a larger precursor).
The important studies of Kasuga and his colleagues and other laboratories (Kasuga et al., 1982a,b; Avruch et al., 19826; Van Obberghen & Kowalski, 1982; Petruzzelli er al., 1982) , have recently demonstrated that solubilized, and even purified, preparations of insulin receptors contain protein-tryosine kinase activity which is greatly enhanced on addition of insulin. At the time of writing the physiological substrates of this kinase are unknown except for the P-subunit of the receptor itself. It is an attractive possibility that dissociation and activation of the proteinserine kinase involved in the increased phosphorylation of acetyl-CoA carboxylase and perhaps other proteins is initiated by the phosphorylation of tyrosine residues by the insulin-receptor kinase. The close association of the insulin receptor and a plasma-membrane protein-serine kinase is suggested by the finding that increased phosphorylation of 607th MEETING, LONDON The reversible phosphorylation of chloroplast photosynthetic membrane (thylakoid) proteins was first reported for peas (Bennett, 1977) but has since been found in a wide range of green plants. There is considerable current interest in identifying the phosphoproteins, in determining the physiological roles of their phosphorylation, and in understanding the regulatory properties of the protein kinase(s) and phosphatase(s) that govern the degree of phosphorylation of each protein. The most conspicuous thylakoid phosphoproteins have apparent molecular masses of about 24 and 26kDa and have been identified as components of the LHCP (Bennett, 1983) . The LHCP is one of several chlorophyll-containing complexes found in the thylakoids. Two of these complexes, known as photosystem I and photosystem 11, contain the reaction centre chlorophyll a Abbreviations used: kDa, kilodaltons; LHCP, light-harvesting chlorophyll a/b protein; PQ, oxidized plastoquinone, PQH2, reduced plastoquinone.
VOl. 12 molecules, which are photochemically active and which initiate electron transport when excited (Cogdell, 1983) . The LHCP is not photochemically active but rather acts as a light-harvesting apparatus for the two photosystems. There is a growing body of evidence that one role of LHCP phosphorylation is to regulate the distribution of excitation energy from LHCP to photosystems I and I1 (see Barber, 1982 Horton, 1983) . This article and those by Allen (1984) and Williams (1984) address aspects of this phenomenon. However, there is also considerable interest in the other thylakoid phosphoproteins and the existence of soluble phosphoproteins should not be ignored (Bennett, 1984) .
LHCP phosphorylation may be studied in vivo in algal cells or leaves, and in vitro in isolated intact chloroplasts or washed thylakoids.
[32P]Orthophosphate may be used for labelling in vivo or in intact chloroplasts, while [y-32P]ATP is more convenient in the case of thylakoids. The protein kinase(s) and phosphatase(s) responsible for the reversible phosphorylation of thylakoid proteins are themselves membrane-bound (Bennett, 1979; . Although the kinase(s) have been more intensively studied than the phosphatase(s), the latter show exceedingly consistent behaviour
